ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF (D) - USD

(BTEE)
Delayed London Stock Exchange  -  11:35 2022-07-05 am EDT
5.537 USD   +0.14%
06/09IShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF Declares Interim Dividend, Payable on 29 June 2022
CI
2021iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF Announces Interim Distribution for the Year 2021, Payable on December 31, 2021
CI
2021Ishares Iv Public Limited Company - Ishares NASDAQ US Biotechnology UCITS ETF Announces Interim Dividend for the year 2021, Payable on 30 June 2021
CI
 SummaryQuotesChartsNewsComponents 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
06/29/2022 06/30/2022 07/01/2022 07/04/2022 07/05/2022 Date
5.4535(c) 5.4205(c) 5.504(c) 5.529(c) 5.537(c) Last
-0.78% -0.61% +1.54% +0.45% +0.14% Change
9 636 9 568 31 071 0 17 189 Volume
More quotes
Investment objective
The iShares Nasdaq US Biotechnology UCITS ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ.
Ratings of iShares Nasdaq US Biotechnology UCITS ETF (D) - USD
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
Composition of ISHARES NASDAQ US BIOTECHNOL...
 CompanyPriceChange1st Jan Change Capi. (M$)Poids  
UnitedAMGEN INC. 246.73 Delayed Quote.0.48%9.67%131 8038.18%
UnitedREGENERON PHARMACEUTICA.. 596.56 Delayed Quote.0.19%-5.54%64 2776.94%
UnitedGILEAD SCIENCES, INC. 62.34 Delayed Quote.-0.03%-14.14%78 1946.94%
UnitedMODERNA, INC. 155.54 Delayed Quote.3.73%-38.76%61 8686.46%
UnitedVERTEX PHARMACEUTICALS 288.98 Delayed Quote.0.58%31.59%73 9086.18%
UnitedILLUMINA, INC. 193.02 Delayed Quote.1.04%-49.26%30 3234.09%
UnitedBIOGEN INC. 212.58 Delayed Quote.0.93%-11.40%31 1332.92%
UnitedSEAGEN INC. 176.77 Delayed Quote.-1.85%14.34%32 5392.5%
UnitedHORIZON THERAPEUTICS PU.. 82.76 Delayed Quote.2.38%-23.20%19 0252.25%
More
All news about ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF (D) - USD
06/09IShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF Declares ..
CI
2021iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF Announces..
CI
2021Ishares Iv Public Limited Company - Ishares NASDAQ US Biotechnology UCITS ETF Announces..
CI
2020IShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF Announces..
CI
2020IShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF Announces..
CI
2019Ishares Iv Public Limited Company -iShares NASDAQ US Biotechnology UCITS ETF Announces ..
CI
2019IShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF Announces..
CI
2018IShares IV Public Limited Company - iShares Edge MSCI World Value Factor UCITS ETF Anno..
CI
More news
All the latest ETF news
07/05Emerging Asian equities post biggest foreign outflows since March 2020
07/04TRACKINSIGHT : U.S. stocks tumble amid fears of inflation and potential recession     
TI
07/04ETF OVERVIEW : Information technology, Consumer staples, Emerging markets
07/04China stocks rise on healthcare boost, ETF Connect launch; HK dips
RE
07/04Vanguard MSCI Australian Large Companies Index ETF Announces Quarterly Distribution
CI
07/04Vanguard FTSE Emerging Markets Shares ETF Announces Distribution for the Quarter Ending..
CI
07/04Vanguard Australian Shares Index ETF Announces Distribution for the Quarter Ended 30 Ju..
CI
07/04Shanghai stocks rise on ETF Connect boost, COVID woes cap gains
RE
More ETF news
Competing ETFs for Index NASDAQ Biotechnology Net Total Return... ETF Data by Trackinsight
ETFVar. 5days1st jan.RatingProviderCategory and Sector
INVESCO NASDAQ BIOTECH ACC 0.85%-19.44%InvescoEquities - Biotechnology
ISHARES NASDAQ US BIOTECHNOL...0.85%-19.43%iSharesEquities - Biotechnology
PROSHARES ULTRA NASDAQ BIOTE...-0.98%-37.75%-ProSharesEquities - Biotechnology
ISHARES NASDAQ US BIOTECHNOL...0.74%-19.82%iSharesEquities - Biotechnology
PROSHARES ULTRASHORT NASDAQ ...-8.50%22.88%-ProSharesEquities - Biotechnology
Plus d'ETFs
News in other languages on ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF (D) - USD
06/09IShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF déclare u..
2021iShares IV Public Limited Company - L'ETF iShares NASDAQ US Biotechnology UCITS annonce..
2021Ishares Iv Public Limited Company - L'Ishares NASDAQ US Biotechnology UCITS ETF annonce..
2020IShares IV Public Limited Company - L'ETF iShares NASDAQ US Biotechnology UCITS annonce..
2020IShares IV Public Limited Company - L'ETF iShares NASDAQ US Biotechnology UCITS annonce..
More news
ETF Ratings by Trackinsight  TrackInsightTM ETF Ratings – Methodology
  More 
Chart ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF (D) - USD
Duration : Period :
iShares Nasdaq US Biotechnology UCITS ETF (D) - USD Technical Analysis Chart | MarketScreener
Full-screen chart
Investment Themes
Asset Classes Equities
Geographical Zones United_States
Sector Biotechnology
Size Large & Mid Cap
Development Developed
Weighting Schemes Market Cap Weighted
Description
Index ETF NASDAQ Biotechnology Net Total Return Index - USD
Related indices
Currency USD
Management fees 0.35%
AuM (2022-05-10) 33.31 M USD
Provider iShares
Features and characteristics
Jurisdiction Ireland
Structure Open-end Investment Company
Date of creation 2018-03-05
Dividend Policy Distribution
Replication Method Direct (Physical)
Replication Model Full Replication
Heatmap :
AuM evolution (2022-05-10)
Last one 33.31 M USD
1-month 33.7 M USD
3 months 31.17 M USD
6 months 36.41 M USD
1-year 26.22 M USD